ArticlePathogens (Basel, Switzerland)2026
Brazilian Propolis in the Context of Pathogens Associated with Neonatal Infections: An Antibacterial and Antiviral Approach.
Anna Livia Oliveira Santos, Nagela Bernadelli Sousa Silva, Júlia Gomes Teixeira, Gabriel Guimarães Calefi, Júlia Amaral Vieira D'Almeida, Natasha Marques Cassani, Ana Carolina Gomes Jardim, Ralciane de Paula Menezes, Marcelo José Barbosa Silva, Matheus Hikaru Tanimoto and 3 more
Abstract read
In one paragraphArticle in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Anna Livia Oliveira SantosLaboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-315, Minas Gerais, Brazil.
Nagela Bernadelli Sousa SilvaLaboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-315, Minas Gerais, Brazil.
Júlia Gomes TeixeiraLaboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-315, Minas Gerais, Brazil.ORCID 0009-0008-8611-7424 Gabriel Guimarães CalefiLaboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-315, Minas Gerais, Brazil.ORCID 0000-0002-1972-9956 Júlia Amaral Vieira D'AlmeidaAntiviral Research Laboratory (LAPAV), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38400-902, Minas Gerais, Brazil.ORCID 0009-0001-6214-2632 Natasha Marques CassaniAntiviral Research Laboratory (LAPAV), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38400-902, Minas Gerais, Brazil.ORCID 0000-0001-9654-0957 Ana Carolina Gomes JardimAntiviral Research Laboratory (LAPAV), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38400-902, Minas Gerais, Brazil.ORCID 0000-0002-6348-7923 Ralciane de Paula MenezesInstitute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-320, Minas Gerais, Brazil.ORCID 0000-0001-8499-9090 Marcelo José Barbosa SilvaInstitute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-320, Minas Gerais, Brazil.ORCID 0000-0002-5807-4286 Matheus Hikaru TanimotoFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto 14040-903, São Paulo, Brazil.ORCID 0000-0002-1063-3026 Victor Pena RibeiroFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto 14040-903, São Paulo, Brazil.ORCID 0000-0002-5015-2446 Jairo Kenupp BastosFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto 14040-903, São Paulo, Brazil.ORCID 0000-0001-8641-9686 Carlos Henrique Gomes MartinsLaboratory of Antimicrobial Testing (LEA), Institute of Biomedical Sciences (ICBM), Universidade Federal de Uberlândia (UFU), Uberlândia 38405-315, Minas Gerais, Brazil.ORCID 0000-0001-8634-6878 Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico 131711/2024-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 310736/2022-6Conselho Nacional de Desenvolvimento Científico e Tecnológico 409187/2023-2Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-01487-22Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ 04640-25Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-04686-22
6 · The paper itselfAbstract
Neonatal infections remain a major global health challenge because of antimicrobial resistance, biofilm-associated persistence, and limited antiviral therapies. This study evaluated the antimicrobial, antibiofilm, in vivo efficacy, and antiviral activities of Brazilian red propolis (BRP) and Brazilian green propolis from the "Caatinga" biome (BGP-C) against pathogens associated with neonatal infections. Antimicrobial activity was determined by broth microdilution, whereas antibiofilm activity was assessed through biofilm biomass and metabolic activity inhibition and structural alterations were evaluated by fluorescence microscopy, and scanning electron microscopy. In vivo efficacy was assessed in a
Indexed as
Anti-Bacterial AgentsAntiviral AgentsPropolisAnimalsBiofilmsBrazilCaenorhabditis elegansHumansMicrobial Sensitivity TestsZika VirusAnti-Bacterial AgentsAntiviral AgentsPropolisantibiofilm activityantimicrobial activityanti-Zika virus activityBrazilian red propolisCaatinga green propolisCaenorhabditis elegansneonatal infections
Identifiers
PMID42796690
PMCPMC13610924
What Socratic holds
Textmetadata
Read underepoch 390